Bayer Bioscience Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 17-06-2024
- Paid Up Capital ₹ 8.36 Cr
as on 17-06-2024
- Company Age 47 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 62.21 Cr
as on 17-06-2024
- Revenue -24.12%
(FY 2023)
- Profit -73.38%
(FY 2023)
- Ebitda 6.82%
(FY 2023)
- Net Worth -61.67%
(FY 2023)
- Total Assets -38.69%
(FY 2023)
About Bayer Bioscience
The Corporate was formerly known as Pioneer Seed Company Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 8.36 Cr.
The company currently has active open charges totaling ₹62.21 Cr.
Pravin Trama, Rupendra Singh, and Simon Wiebusch serve as directors at the Company.
- CIN/LLPIN
U74899MH1977PTC179722
- Company No.
179722
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Feb 1977
- Date of AGM
22 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane West, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Bayer Bioscience?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Simon Wiebusch  | Director | 23-Jan-2019 | Current |
Pravin Trama  | Director | 01-Oct-2019 | Current |
| Rupendra Singh | Whole-Time Director | 25-May-2022 | Current |
Financial Performance and Corporate Structure Insights of Bayer Bioscience.
Bayer Bioscience Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 24.12% decrease. The company also saw a substantial fall in profitability, with a 73.38% decrease in profit. The company's net worth observed a substantial decline by a decrease of 61.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bayer Bioscience?
In 2023, Bayer Bioscience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mahyco Monsanto Biotech (India) Private LimitedActive 27 years 1 monthPravin Trama and Simon Wiebusch are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indusind Bank Ltd. Creation Date: 03 Jun 1997 | ₹3.80 Cr | Open |
State Bank Of Travancore Creation Date: 03 Jan 1997 | ₹21.75 Cr | Open |
Syndicate Bank Creation Date: 29 Mar 1995 | ₹1.00 Cr | Open |
How Many Employees Work at Bayer Bioscience?
Unlock and access historical data on people associated with Bayer Bioscience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bayer Bioscience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bayer Bioscience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
